Cargando…
Enhancement of in vitro antitumour activity of epirubicin in HER2+ breast cancer cells using immunoliposome formulation
Epirubicin (EPI) is one of the potent breast cancer (BC) chemotherapeutic agents, but its adverse effects limit its efficacy. Herein, EPI was selected to be loaded in liposomal carrier, which has been targeted by a monoclonal antibody, Herceptin. The preparation process of liposomes was a modified e...
Autores principales: | Khaleseh, Farnaz, Hemmati Azandaryani, Abbas, Fathian Kolahkaj, Fatemeh, Khazaei, Mozafar, Derakhshandeh, Katayoun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675807/ https://www.ncbi.nlm.nih.gov/pubmed/34694666 http://dx.doi.org/10.1049/nbt2.12012 |
Ejemplares similares
-
The Role of Nanoparticle in Brain Permeability: An in-vitro BBB Model
por: Nikandish, Niusha, et al.
Publicado: (2016) -
New surface-modified solid lipid nanoparticles using N-glutaryl phosphatidylethanolamine as the outer shell
por: Kashanian, Soheila, et al.
Publicado: (2011) -
Pharmacokinetic study of furosemide incorporated PLGA microspheres after oral administration to rat
por: Derakhshandeh, Katayoun, et al.
Publicado: (2016) -
Characterization of highly stable liposomal and immunoliposomal formulations of vincristine and vinblastine
por: Noble, Charles O., et al.
Publicado: (2009) -
Immunoliposomes with Simvastatin as a Potential Therapeutic in Treatment of Breast Cancer Cells Overexpressing HER2—An In Vitro Study
por: Matusewicz, Lucyna, et al.
Publicado: (2018)